Newsfeeds - Spark Newswire

2 minute read

Mid-Afternoon Market Update: Dow Surges 150 Points; Applied Therapeutics Shares Slide

Today, 10:46 AM

Toward the end of trading Monday, the Dow traded up 0.43% to 36,496.18 while the NASDAQ rose 0.93% to 15,790.97. The S&P also rose, gaining 0.43% to 4,786.68.

APLT

1 minute read

10 Biggest Price Target Changes For Tuesday

By Lisa Levin

Today, 10:46 AM

Keybanc lifted Reliance Steel & Aluminum Co. (NYSE: RS) price target from $165 to $175. Reliance Steel shares rose 1.4% to $166.24 in pre-market trading.

1 minute read

Cowen & Co. Upgrades Calumet Specialty to Outperform, Raises Price Target to $23

By Benzinga Newsdesk

Today, 10:46 AM

Cowen & Co. analyst Jason Gabelman upgrades Calumet Specialty (NASDAQ:CLMT) from Market Perform to Outperform and raises the price target from $12 to $23.

CLMT

5 minute read

64 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:46 AM

Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile Electric Vehicle charging solutions for a full range of applications.

ALHC

6 minute read

Earnings Scheduled For November 5, 2021

By Benzinga Insights

Today, 10:46 AM

Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEPC) is projected to report earnings for its third quarter.

AMCX

1 minute read

Earnings

Calumet Specialty’s Earnings Outlook

By Benzinga Insights

Today, 10:46 AM

Calumet Specialty (NASDAQ:CLMT) is set to give its latest quarterly earnings report on Friday, 2021-11-05. Here's what investors need to know before the announcement. Analysts estimate that Calumet Specialty will likely report an Earnings Per Share (EPS) of $-0.15

CLMT

1 minute read

Wells Fargo Maintains Overweight on Calumet Specialty, Raises Price Target to $11

By Benzinga Newsdesk

Today, 10:46 AM

Wells Fargo analyst Roger Read maintains Calumet Specialty (NASDAQ:CLMT) with a Overweight and raises the price target from $8 to $11.

CLMT

1 minute read

HC Wainwright & Co. Initiates Coverage On Calumet Specialty with Buy Rating, Announces Price Target of $19

By Benzinga Newsdesk

Today, 10:46 AM

HC Wainwright & Co. analyst Amit Dayal initiates coverage on Calumet Specialty (NASDAQ:CLMT) with a Buy rating and announces Price Target of $19.

CLMT

4 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:46 AM

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share.

ACH

3 minute read

36 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 10:46 AM

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results.

ACH